Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("THIGPEN J")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 65

  • Page / 3
Export

Selection :

  • and

Lord of all the earth : Yahweh and Baal in Joshua 3THIGPEN, J. Michael.Trinity journal. 2006, Vol 27, Num 2, pp 245-254, issn 0360-3032, 10 p.Article

ADRIAMYCIN IN COMBINATION FOR THE TREATMENT OF BREAST CANCER. A SOUTHWEST ONCOLOGY GROUP STUDY.TRANUM B; HOOGSTRATEN B; KENNEDY A et al.1978; CANCER; USA; DA. 1978; VOL. 41; NO 6; PP. 2078-2083; BIBL. 10 REF.Article

Chemotherapy for advanced ovarian cancer : Overview of randomized trialsTHIGPEN, J. T.Seminars in oncology. 2000, Vol 27, Num 3, pp 11-16, issn 0093-7754, SUP7Conference Paper

Limited-stage ovarian carcinomaTHIGPEN, J. T.Seminars in oncology. 1999, Vol 26, Num 6, pp 29-33, issn 0093-7754, SUP18Conference Paper

High-dose chemotherapy in ovarian carcinomaHERRIN, V. E; THIGPEN, J. T.Seminars in oncology. 1999, Vol 26, Num 1, pp 99-105, issn 0093-7754Article

Management of stage I and II ovarian carcinomaTATE THIGPEN, J; LAMBUTH, B. W; VANCE, R. B et al.Seminars in oncology. 1991, Vol 18, Num 6, pp 596-602, issn 0093-7754Article

Cisplatin as second-line chemotherapy in the treatment of advanced or recurrent leiomyosarcoma of the uterus. A phase II trial of the gynecologic oncology groupTHIGPEN, J. T; BLESSING, J. A; WILBANKS, G. D et al.American journal of clinical oncology. 1986, Vol 9, Num 1, pp 18-20, issn 0277-3732Article

Cis-platinum in the treatment of advanced or recurrent adenocarcinoma of the ovary: a phase II study of the Gynecologic Oncology Group = Cisplatine et adénocarcinomes récidivants ou avancés de l'ovaire: une étude phase II du Gynecologic Oncology GroupTHIGPEN, J. T; LAGASSE, L; HOMESLEY, H et al.American journal of clinical oncology. 1983, Vol 6, Num 4, pp 431-435, issn 0277-3732Article

The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer : a gynecologic oncology group studyHOSKINS, W. J; BUNDY, B. N; THIGPEN, J. T et al.Gynecologic oncology (Print). 1992, Vol 47, Num 2, pp 159-166, issn 0090-8258Conference Paper

Phase II trial of piperazinedione in the treatment of advanced or recurrent endometrial carcinoma. A gynecologic oncology group studyTHIGPEN, J. T; BLESSING, J. A; HOMESLEY, H. D et al.American journal of clinical oncology. 1986, Vol 9, Num 1, pp 21-23, issn 0277-3732Article

Phase II study of maytansine in the treatment of advanced or recurrent adenocarcinoma of the ovary: a Gynecologic Oncology Group study = Essai phase II de la maytansine dans les adénocarcinomes ovariens avancés ou en rechute. Une étude du Gynecologic Oncology GroupTHIGPEN, J. T; EHRLICH, C. E; CREASMAN, W. T et al.American journal of clinical oncology. 1983, Vol 6, Num 3, pp 273-275, issn 0277-3732Article

Phase II trial of piperazinedione (NCS 135758) in the treatment of advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study = Essai phase II de la pipérazinedione (NSC 135758) dans le traitement des épithéliomas épidermoïdes avancés de récidivants du col utérin: une étude du Gynecologic Oncology GroupTHIGPEN, J. T; BLESSING, J; HOMESLEY, H. D et al.American journal of clinical oncology. 1983, Vol 6, Num 4, pp 423-426, issn 0277-3732Article

Cisplatin as second-line therapy in ovarian carcinoma treated initially with single-agent paclitaxel: a Gynecologic Oncology Group studyTHIGPEN, J. Tate; BLESSING, John A; OLT, George et al.Gynecologic oncology (Print). 2003, Vol 90, Num 3, pp 581-586, issn 0090-8258, 6 p.Article

Organization and function of a hospital ethics committeeSEXSON, W. R; THIGPEN, J.Clinics in perinatology. 1996, Vol 23, Num 3, issn 0095-5108, vii, 429-436 [9 p.]Article

Phase II trial of piperazinedione in patients with advanced or recurrent uterine sarcoma: a gynecologic oncology group studyTATE THIGPEN, J; BLESSING, J. A; HOMESLEY, H. D et al.American journal of clinical oncology. 1985, Vol 8, Num 5, pp 350-352, issn 0277-3732Article

Increased microvascular permeability in dog lungs due to high peak airway pressuresPARKER, J. C; TOWNSLEY, M. I; RIPPE, B et al.Journal of applied physiology: respiratory, environmental and exercise physiology. 1984, Vol 57, Num 6, pp 1809-1816, issn 0161-7567Article

Basal cell carcinoma with lung metastasis diagnosed by fine-needle aspiration biopsyPATEL, M. S; THIGPEN, J. T; VANCE, R. B et al.Southern medical journal (Birmingham). 1999, Vol 92, Num 3, pp 321-324, issn 0038-4348Article

Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a gynecologic oncology group studyTATE THIGPEN, J; BLESSING, J. A; HOMESLEY, H et al.Gynecologic oncology (Print). 1989, Vol 33, Num 1, pp 68-70, issn 0090-8258Article

Hexamethylmelamine as first-line chemotherapy in the treatment of advanced or recurrent carcinoma of the endometrium: a phase II trial of the gynecologic oncology groupTHIGPEN, J. T; BLESSING, J. A; BALL, H et al.Gynecologic oncology (Print). 1988, Vol 31, Num 3, pp 435-438, issn 0090-8258Article

Phase II trial of cisplatin in the treatment of patients with advanced or recurrent mixed mesodermal sarcomas of the uterus: a gynecologic oncology group studyTATE THIGPEN, J; BLESSING, J. A; ORR, J. W. JR et al.Cancer treatment reports. 1986, Vol 70, Num 2, pp 271-274, issn 0361-5960Article

Nutrition, cancer, and aging: an annotated review. II: Cancer cachexia and agingHARDY, C; WALLACE, C; TAWFIQ KHANSUR et al.Journal of the American Geriatrics Society. 1986, Vol 34, Num 3, pp 219-228, issn 0002-8614Article

Growth characteristics of large- and small-colony types of Mycoplasma mycoides subsp. mycoides on 5% sheep blood agarTHIGPEN, J. E; COTTEW, G. S; YEATS, F et al.Journal of clinical microbiology (Print). 1983, Vol 18, Num 4, pp 956-960, issn 0095-1137Article

Chemotherapy as a palliative treatment in carcinoma of the uterine cervixTHIGPEN, J. T; VANCE, R; PUNEKY, L et al.Seminars in oncology. 1995, Vol 22, Num 2, pp 16-24, issn 0093-7754, SUP3Conference Paper

The Cordilleran foreland thrust belt in Northwestern Montana and Northerm Idaho from COCORP and industry seismic reflection dataYOOS, T. R; POTTER, C. J; THIGPEN, J. L et al.AAPG bulletin. 1991, Vol 75, Num 6, pp 1089-1106, issn 0149-1423, 18 p.Article

Chemotherapy of advanced squamous carcinoma of the cervix: a phase I-II study of high-dose cisplatin and cyclophosphamide. A pilot study of the gynecologic oncology groupJOBSON, V. W; MUSS, H. B; THIGPEN, J. T et al.American journal of clinical oncology. 1984, Vol 7, Num 4, pp 341-345, issn 0277-3732Article

  • Page / 3